NT-3 gene therapy (CHUV/Zurich)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNT-3 gene therapy (CHUV/Zurich)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionNeurotrophin-3 ligand
TargetsNeurotrophin-3
Therapy Area/IndicationsMotor Neuron Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentre Hospitalier Universitaire Vaudois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of ZurichCentre Hospitalier Universitaire Vaudois
Active IndicationsN/A
Inactive IndicationsMotor Neuron Disease

Other Information

ATC CodeN/A
Related LinksN/A